In addition, the lung cancer patients with the higher p-PDHA1 and PKM2 levels, when determined by Western blotting of tumor samples (Figure 6L,M,O), markedly reduced survival probability (Figure 6N–P and Supplementary Figure S3B). This evidence concerns the gene PKM and lung carcinoma.